Skip to content
DataLookout
Menu

NCT07282483

Traditional Chinese Medicine Oral Liquids and Mouthwashes for Radiation-induced Oral Mucositis in Head and Neck Cancer Patients

StatusRecruiting
PhasePhase 2
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 12 words
    • Primary completion date changed from estimate of Aug 31, 2026 to Oct 25, 2026
    • Study completion pushed from Oct 31, 2026 to Dec 25, 2026
  2. Minor Study completion date: Sep 30, 2026 to Oct 31, 2026
    • Start date changed from estimate of Mar 20, 2026 to Mar 16, 2026
    • Secondary endpoints: 8 to 5
    v3
  3. Notable Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Start date: Dec 15, 2025 to Mar 20, 2026
    • Primary completion date: Mar 31, 2026 to Aug 31, 2026
    • Study completion date: May 31, 2026 to Sep 30, 2026
    • Site details revised
  4. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Incidence rate of severe oral mucositis (RTOG grade ≥ 3)
Timeframe: From the start of radiotherapy to 8 weeks after the end of radiotherapy. The evaluation period is approximately 14 to 14.5 weeks

Secondary (5)

Duration of mild-to-moderate RIOM
The time to onset of any-grade oral mucositis (OM)
RIOM remission rates at 4 and 8 weeks after completion of radiotherapy
Duration of oral mucositis (OM)
Adverse events

Arms and interventions

Qingying oral liquid and modified Da Huang-Huang Lian Xiexin mouthwashActive comparator
Placebo oral solution and mouthwashPlacebo comparator

Drugs: Qingying oral liquid and modified Da Huang-Huang Lian Xiexin mouthwash, Placebo oral solution and mouthwash

Radiation: radiotherapy

Sites

1 site in 1 country

  • West China HospitalChengdu, Sichuan, China